Pharmacist–physician collaboration for developing an in-hospital guideline for the proper use of recombinant human erythropoietin, provision of drug information on CKD-associated anemia to physicians and nurses; involvement included: ordering laboratory tests; medication adjustments, education/counselling, and development of management plans. This evidence concerns the gene EPO and chronic kidney disease.